Quest Diagnostics (DGX) PT Raised to $96 at Jefferies Following 4Q Earnings Report
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/25/2026
- Nasdaq futures jump 2% as Micron, Qualcomm forecasts ease AI concerns; PCE data awaited
- Micron posts record profit as AI memory demand fuels explosive growth
- Brent settles at lowest since before start of Iran war as more tankers exit Hormuz
- IBM surges on unveiling sub-1nm chip technology breakthrough
- Alphabet added to Dow Jones Industrial Average, Verizon dropped
Quest Diagnostics Reports Fourth Quarter And Full Year 2016 Financial Results; Provides Guidance For Full Year 2017
January 26, 2017 6:45 AM ESTMADISON, N.J., Jan. 26, 2017 /PRNewswire/ --Â Quest Diagnostics Incorporated (NYSE: DGX), the world's leading provider of diagnostic information services, announced today financial results for the fourth quarter and full year ended December 31, 2016.
Â
"We grew revenues, operating income, margins and operating cash flow in the fourth quarter, capping a strong year in which we achieved our commitments and created value for shareholders," said Steve Rusckowski, Chairman, CEO and President. "We are laser focused on our two point strategy to... More
Quest Diagnostics Partners With Montefiore Health System to Deliver High-Value, Innovative Laboratory Services
January 26, 2017 6:00 AM ESTMADISON, N.J. and NEW YORK, Jan. 26, 2017 /PRNewswire/ -- Quest Diagnostics (NYSE: DGX), the world's leading provider of diagnostic information services, is working with  Montefiore Health System (MHS) to provide diagnostic laboratory services. This partnership will enhance the quality and efficiency of laboratory services at Montefiore.
"We are pleased to partner with Montefiore, a premiere academic health system recognized for personalized, accountable care," said Steve Rusckowski, Chairman, President and CEO, Quest Diagnostics. "As part of our strategy to accelerate growth and drive operational excellence, Quest is... More
